Feb 12, 2018   SOURCE: PR NewsWire

Pomona Valley Hospital Medical Center Adopting In-House IV Compounding with Omnicell's IV Robotics

MOUNTAIN VIEW, Calif., Feb. 12, 2018 /PRNewswire/ -- Omnicell, Inc., (NASDAQ: OMCL), today announced that California's Pomona Valley Hospital Medical Center (PVHMC) has chosen to automate sterile compounding in their pharmacy operations with Omnicell IV solutions, part of the Company's industry-leading medication management automation platform. Leveraging Omnicell's robotic technology will help PVHMC to support patient safety, while reducing costs previously associated with outsourcing sterile compounding services. PVHMC plans to implement the robots in May, with compounding operations beginning later this year.

PVHMC joins many leading health systems who are adopting recommendations by The Institute for Safe Medication Practices (ISMP) for the implementation of automation and technology in sterile compounding.(1) PVHMC is among the top 10% of all short-term acute care hospitals in the United States to receive the Healthgrades(®) Patient Safety Excellence Award.(2)

The medical center will implement two i.v.STATION(TM) non-hazardous compounding robots to drive improvements in their sterile compounding operation. With the smallest footprint on the market, i.v.STATION helps hospitals and health systems to further enhance patient safety, improve therapy, reduce cost, and facilitate compliance in the IV room.

"As a director, I'm tasked with ensuring that patient safety is our top priority, while still reducing expenses," said Michael Campbell, PharmD, MBA, director of pharmacy at Pomona Valley Hospital Medical Center. "IV robotics will help us streamline our compounding processes, allowing us to redirect financial and clinical time savings to activities that support clinical care. By improving our processes, we're able to deliver the best products to patients."

"Ensuring IV doses are prepared safely, accurately, and cost-effectively is oftentimes overwhelming for hospital pharmacies," said Doug Descalzi, vice president and GM, IV Solutions at Omnicell. "We're committed to partnering with customers like PVHMC to deliver automation solutions and services that support their needs today, but also grow as healthcare challenges continue to evolve."

About Pomona Valley Hospital Medical Center
Pomona Valley Hospital Medical Center (PVHMC), a nationally recognized and accredited 437-bed, not-for-profit community medical center and trauma center, proudly serves residents in eastern Los Angeles and western San Bernardino counties. PVHMC's accolades include The Joint Commission's Gold Seal of Approval® for advanced certification in inpatient diabetes care, palliative care, sepsis, perinatal care and total joint replacement. It is also the only hospital in Los Angeles, Riverside and San Bernardino counties to receive all three Healthgrades® Women's Care Five Star Excellence Awards(TM) for its exemplary work providing women with labor and delivery, gynecologic surgery and obstetrics and gynecology care. As the second largest birthing hospital in California, PVHMC is honored to hold the prestigious Baby-Friendly designation. The Hospital is among the top 10% of all short-term acute care hospitals in the United States to receive the Healthgrades® Patient Safety Excellence Award. For more information, visit pvhmc.org.

About Omnicell

Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to create safer and more efficient ways to manage medications and supplies across all care settings. Omnicell is revolutionizing the patient medication experience from hospital to home by empowering providers to keep each patient at the center of care. The Company's autonomous approach to medication management leverages a differentiated platform for hardware and workflow software solutions, real-time predictive intelligence, and performance-driven partnerships to help drive operational, financial, and clinical success for customers.

Supporting the highest level of patient safety is essential to excellent patient care. As a leader in medication and supply dispensing automation, central pharmacy automation, IV robotics, analytics software, and medication adherence and packaging systems, Omnicell is focused on delivering solutions for medication availability, affordability, safety, and adherence. Over 4,000 customers worldwide use Omnicell(®) automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety.

Omnicell's innovative medication adherence solutions, used by over 32,000 institutional and retail pharmacies in North America and the United Kingdom, are designed to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions.

For more information about Omnicell, Inc. please visit www.omnicell.com.

OMCL-G

Footnotes:
(1) http://www.ismp.org/tools/guidelines/ivsummit/ivcguidelines.pdf
(2 )https://www.healthgrades.com/quality/patient-safety-excellence-award-recipients-2017

Editor's Notes:

    1. All Omnicell news releases (financial, acquisitions, products, technology
       etc.) are issued exclusively by PR Newswire and are immediately
       thereafter posted on the company's external website, omnicell.com.
    2. Omnicell and the Omnicell logo design are registered trademarks of
       Omnicell, Inc.
    3. All other brand or product names may be trademarks or registered
       trademarks of their respective companies.

View original content with multimedia:http://www.prnewswire.com/news-releases/pomona-valley-hospital-medical-center-adopting-in-house-iv-compounding-with-omnicells-iv-robotics-300596966.html

SOURCE Omnicell, Inc.